[go: up one dir, main page]

AU2003298708A1 - GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER - Google Patents

GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER

Info

Publication number
AU2003298708A1
AU2003298708A1 AU2003298708A AU2003298708A AU2003298708A1 AU 2003298708 A1 AU2003298708 A1 AU 2003298708A1 AU 2003298708 A AU2003298708 A AU 2003298708A AU 2003298708 A AU2003298708 A AU 2003298708A AU 2003298708 A1 AU2003298708 A1 AU 2003298708A1
Authority
AU
Australia
Prior art keywords
gpc99a
gpc99
compositions
methods
treating cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003298708A
Other versions
AU2003298708A8 (en
Inventor
Karuppiah Kannan
Ronan C. O'hagan
Rijian Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aveo Pharmaceuticals Inc
Original Assignee
Genpath Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genpath Pharmaceuticals Inc filed Critical Genpath Pharmaceuticals Inc
Publication of AU2003298708A8 publication Critical patent/AU2003298708A8/en
Publication of AU2003298708A1 publication Critical patent/AU2003298708A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003298708A 2002-11-27 2003-11-26 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER Abandoned AU2003298708A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42987702P 2002-11-27 2002-11-27
US60/429,877 2002-11-27
PCT/US2003/037813 WO2004050834A2 (en) 2002-11-27 2003-11-26 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER

Publications (2)

Publication Number Publication Date
AU2003298708A8 AU2003298708A8 (en) 2004-06-23
AU2003298708A1 true AU2003298708A1 (en) 2004-06-23

Family

ID=32469383

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003298708A Abandoned AU2003298708A1 (en) 2002-11-27 2003-11-26 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER

Country Status (2)

Country Link
AU (1) AU2003298708A1 (en)
WO (1) WO2004050834A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0521139D0 (en) * 2005-10-18 2005-11-23 Univ Sheffield Therapeutic agent
GB0708002D0 (en) * 2007-04-25 2007-06-06 Univ Sheffield Antibodies
JP5099856B2 (en) * 2007-11-26 2012-12-19 独立行政法人科学技術振興機構 Metabolic syndrome treatment or prevention agent, test method, test drug, and screening method for candidate compound of metabolic syndrome treatment drug
CA3075867A1 (en) * 2017-09-13 2019-03-21 Gene Techno Science Co., Ltd. Anti-ramp2 antibody
CN110075276A (en) * 2019-03-29 2019-08-02 中国人民解放军陆军军医大学第一附属医院 Application of the ADM competitive antagonist AMA in anti-glioma angiogenesis treatment
CN110090297B (en) * 2019-03-29 2021-05-14 中国人民解放军陆军军医大学第一附属医院 Use of ADM competitive antagonist AMA in glioma immunotherapy
GB202303531D0 (en) * 2023-03-10 2023-04-26 Fusion Antibodies Plc Antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU745623B2 (en) * 1997-12-24 2002-03-28 Immunex Corporation V196 DNA and polypeptides

Also Published As

Publication number Publication date
AU2003298708A8 (en) 2004-06-23
WO2004050834A2 (en) 2004-06-17
WO2004050834A3 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
AU2003230750A1 (en) Compositions and methods for treating cancer
EP2671581B8 (en) Compositions and methods for treating cancer
AU2003293194A1 (en) Compositions and methods for treating prostate cancer
AU2003225535A1 (en) Methods and compositions for treating cancer
AU2003284242A1 (en) Methods and compositions for use in treating cancer
WO2003073826A8 (en) Novel compositions and methods for cancer
AU2003291356A1 (en) Methods and compositions for treating cancer using proteasome inhibitors
AU2003226301A1 (en) Method of treating cancer
AU2003243373A1 (en) Cell migration inhibiting compositions and methods and compositions for treating cancer
AU2003256847A1 (en) Method of treating cancer
EP1572118A4 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2003297573A1 (en) Compositions and methods for treating transplants
AU2003212850A1 (en) Methods and compositions for treating cardiovascular disease
AU2003219160A1 (en) Methods and compositions for the treatment of cancer
AU2003238905A1 (en) Surface treating compositions and methods for using same
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
AU2003298708A1 (en) GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER
AU2002337943A1 (en) Novel compositions and methods for cancer
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2003275433A1 (en) Compositions and methods for treating pain
EP1587405A4 (en) Novel compositions and methods for cancer
AU2003291730A1 (en) Methods and compositions for treating neurodegenerative diseases
AU2003300171A1 (en) Compositions and methods for treating lung cancer
AU2003295604A1 (en) Gpc15: methods and compositions for treating cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase